Biotech

ApexHub

ApexHub Raises $20M Seed to Transform Biotech

$20M Seed
Total Raised
Seed
Latest Round
2018
Founded
10-50
Employees
Denver, CO
1 min read

Quick Facts

Valuation
$100M
Latest Round Size
$20M Seed
Latest Round Date
October 2025

ApexHub Raises $20M Seed in Latest Funding Round

ApexHub has successfully closed a $20M Seed funding round, marking a significant milestone in the company's growth trajectory. The round was led by Benchmark, with participation from Lightspeed Venture Partners.

Company Overview

Founded in 2018 and headquartered in Denver, CO, ApexHub has established itself in the Biotech space. Leading AI-powered analytics platform transforming data into actionable business insights

With a current valuation of $100M, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $20M Seed
  • Valuation: $100M
  • Lead Investor: Benchmark

Future Outlook

As ApexHub moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.

Key Investors

Benchmark
Venture Capital
Leading venture capital firm investing in technology companies
Lightspeed Venture Partners
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Sarah Kim
Sarah Kim
Healthcare and biotech investment analyst with expertise in Series B+ rounds and strategic partnerships.